Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying Hong

Showing results (1121-1130 of 1,220) with videos related to

Pageof 122
Sort By:
Phytochemistry|August 29, 2024
Recent progress on triterpenoid derivatives and their anticancer potentialZi-Xuan Zhao, Qiong-Yu Zou, Ying-Hong Ma, et al.
Pharmacological Research|August 19, 2024
Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in miceJunli Ma, Mingxiao Li, Yiyang Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgeryXin-Rong Yang, Yang Xu, Bin Yu, et al.
Cell Death & Disease|April 16, 2025
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristicsYou-Xin Gao, Xiao-Jing Guo, Bin Lin, et al.
International Urology and Nephrology|January 22, 2017
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trialHong Ren, Xiao Li, Zhao-Hui Ni, et al.
Journal of Cancer|March 28, 2018
A Novel Risk prediction Model for Patients with Combined Hepatocellular-CholangiocarcinomaMeng-Xin Tian, Wen-Jun He, Wei-Ren Liu, et al.
Frontiers in Medicine|December 28, 2020
Management of Cervical Cancer in Pregnant Women: A Multi-Center Retrospective Study in ChinaMingzhu Li, Yun Zhao, Mingrong Qie, et al.
Progress in Retinal and Eye Research|October 12, 2025
Microbiome signatures and their role in uveitis: Pathogenesis, diagnostics, and therapeutic perspectivesKajal Agrawal, Ashley Shuen Ying Hong, Carlos Cifuentes-González, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 14, 2022
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaGui-Qi Zhu, Yi Wang, Biao Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 20, 2019
UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signalingJian-Xian Lin, Xin-Sheng Xie, Xiong-Feng Weng, et al.
Pageof 122

Showing results (1121-1130 of 1,220) with videos related to

Sort By:
Pageof 122
Phytochemistry|August 29, 2024
Recent progress on triterpenoid derivatives and their anticancer potentialZi-Xuan Zhao, Qiong-Yu Zou, Ying-Hong Ma, et al.
Pharmacological Research|August 19, 2024
Gut microbiota-brain bile acid axis orchestrates aging-related neuroinflammation and behavior impairment in miceJunli Ma, Mingxiao Li, Yiyang Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgeryXin-Rong Yang, Yang Xu, Bin Yu, et al.
Cell Death & Disease|April 16, 2025
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristicsYou-Xin Gao, Xiao-Jing Guo, Bin Lin, et al.
International Urology and Nephrology|January 22, 2017
Treatment of complicated urinary tract infection and acute pyelonephritis by short-course intravenous levofloxacin (750 mg/day) or conventional intravenous/oral levofloxacin (500 mg/day): prospective, open-label, randomized, controlled, multicenter, non-inferiority clinical trialHong Ren, Xiao Li, Zhao-Hui Ni, et al.
Journal of Cancer|March 28, 2018
A Novel Risk prediction Model for Patients with Combined Hepatocellular-CholangiocarcinomaMeng-Xin Tian, Wen-Jun He, Wei-Ren Liu, et al.
Frontiers in Medicine|December 28, 2020
Management of Cervical Cancer in Pregnant Women: A Multi-Center Retrospective Study in ChinaMingzhu Li, Yun Zhao, Mingrong Qie, et al.
Progress in Retinal and Eye Research|October 12, 2025
Microbiome signatures and their role in uveitis: Pathogenesis, diagnostics, and therapeutic perspectivesKajal Agrawal, Ashley Shuen Ying Hong, Carlos Cifuentes-González, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 14, 2022
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular CarcinomaGui-Qi Zhu, Yi Wang, Biao Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 20, 2019
UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signalingJian-Xian Lin, Xin-Sheng Xie, Xiong-Feng Weng, et al.
Pageof 122